Abstract 5652: Olverembatinib (HQP1351) in combination with lisaftoclax (APG-2575) overcomes venetoclax resistance in preclinical models of acute myeloid leukemia (AML)
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Yan Xiong, Zhiyan Liang, Ping Min, Bingxing Wu, Huidan Yu, Guoqin Zhai, Zhou Yu, Dajun Yang, Yifan Zhai
Institution: Ascentage Pharma Group Inc. (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631197